Each CAH carrier was found to have damaging heterozygous variants or heterozygous deletion of CYP21A2. In one particular carrier, damaging variants g.655C>G and g.2444G>A were observed in cis configuration, with the other copy of the gene unaffected. This evidence concerns the gene CYP21A2 and congenital adrenal hyperplasia.